Abstract.
Transforming growth factor-β1 (TGF-β1) has been shown to modulate β-adrenoceptor number and function in cultured human tracheal smooth muscle cells and cardiac fibroblasts, but the mechanism is unclear. In this study, we have characterized the β2-adrenoceptor expression by radioligand binding assay, Northern blot analysis and measurement of intracellular cAMP accumulation in a human embryonic lung fibroblast cell line (HEL299 cells). Treatment with TGF-β1 caused a time-dependent decrease in β2-adrenoceptor mRNA, and in receptor number after 24 h. Furthermore, nuclear run-on assays showed a 35% reduction in the transcription rate of the β2-adrenoceptor gene with no alteration in stability of the β2-adrenoceptor mRNA. After TGF-β1 treatment, the basal, procaterol- and forskolin-stimulated cAMP accumulations were also decreased. Cycloheximide inhibited TGF-β1-mediated reduction of β2-adrenoceptor mRNA and protein, whilst alone caused induction of β2-adrenoceptor mRNA without any effect on receptor number. In summary, TGF-β1 induces β2-adrenoceptor desensitization through the alteration in adenylyl cyclase activity and down-regulation of β2-adrenoceptor mRNA and protein through the reduction in the rate of β2-adrenoceptor gene transcription.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Electronic Publication
Rights and permissions
About this article
Cite this article
Mak, J., Rousell, J., Haddad, EB. et al. Transforming growth factor-β1 inhibits β2-adrenoceptor gene transcription. Naunyn-Schmied Arch Pharmacol 362, 520–525 (2000). https://doi.org/10.1007/s002100000321
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s002100000321